Concepedia

Publication | Open Access

Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors

DOIFull Paper Access

154

Citations

22

References

2021

Year

François Doz, Cornelis M. van Tilburg, Birgit Geoerger, Martin Højgaard, Ingrid Øra, Valentina Boni, Michael Capra, Julia Chisholm, Hyun Cheol Chung, Steven G. DuBois,
Neuro-Oncology

Abstract

In patients with TRK fusion-positive CNS tumors, larotrectinib demonstrated rapid and durable responses, high disease control rate, and a favorable safety profile.

References

YearCitations

Page 1